Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.51 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.81.
Market Cap
9.51T
Revenue
4.67T
Profits
187.12B
PE Ratio
50.81
Profit Margin
4.01%
Dividend Yield
0.37%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 0.22% | 1,136,108 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 662.38B | 1.35% | 4,252,647 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 460.46B | 0.22% | 2,085,152 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 373.14B | 0.92% | 3,740,002 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 359.02B | 0.93% | 1,682,218 | 450.53B |
| 6 | NVS | Novartis AG | 306.77B | 0.19% | 3,473,651 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.99B | -0.71% | 1,908,897 | 61.37B |
| 8 | AMGN | Amgen Inc. | 237.81B | 0.40% | 1,074,739 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 225.01B | 1.34% | 874,243 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.96B | 4.01% | 6,871,850 | 50.34B |
| 11 | ABT | Abbott Laboratories | 192.21B | 1.97% | 4,709,044 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 185.63B | -0.14% | 2,283,327 | 30.46B |
| 13 | PFE | Pfizer Inc. | 164.78B | 1.26% | 22,161,397 | 63.70B |
| 14 | DHR | Danaher Corporation | 147.99B | 1.73% | 1,710,604 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 140.49B | 1.21% | 1,118,965 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.75B | 0.77% | 2,901,913 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.78B | 0.25% | 1,053,055 | 11.03B |
| 18 | CVS | CVS Health Corporation | 125.15B | 0.26% | 2,774,084 | 412.65B |
| 19 | SYK | Stryker Corporation | 119.87B | -1.54% | 1,119,185 | 25.84B |
| 20 | MDT | Medtronic plc | 119.14B | 1.13% | 5,154,977 | 37.54B |
| 21 | MCK | McKesson Corporation | 107.74B | 1.91% | 349,824 | 410.98B |
| 22 | SNY | Sanofi | 107.16B | 0.50% | 1,006,558 | 55.89B |
| 23 | GSK | GSK plc | 100.74B | -0.53% | 1,916,173 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 88.46B | -1.21% | 747,619 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 88.37B | 1.10% | 372,412 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 85.06B | 3.41% | 394,617 | 15.53B |
| 27 | CI | The Cigna Group | 74.69B | -0.14% | 432,101 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.02B | 1.92% | 9,335,263 | 21.00B |
| 29 | ARGX | argenx SE | 64.25B | 1.67% | 138,539 | 5.32B |
| 30 | COR | Cencora, Inc. | 64.15B | 1.58% | 657,013 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 60.01B | -2.56% | 11,864,677 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.62B | 0.99% | 1,235,136 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 57.00B | 2.40% | 634,299 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.49B | 0.36% | 871,250 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.56B | 1.17% | 579,193 | 22.48B |
| 36 | HUM | Humana Inc. | 48.69B | 2.68% | 541,921 | 145.68B |
| 37 | MDLN | Medline Inc. | 47.46B | 2.82% | 5,819,575 | 29.94B |
| 38 | NTRA | Natera, Inc. | 46.28B | 0.10% | 658,334 | 2.71B |
| 39 | VEEV | Veeva Systems Inc. | 45.53B | 0.72% | 690,199 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.63B | -0.79% | 668,088 | - |
| 41 | HLN | Haleon plc | 44.08B | -1.09% | 8,125,435 | 14.80B |
| 42 | IQV | IQVIA Holdings Inc. | 43.68B | 2.72% | 508,117 | 16.98B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.48B | 3.09% | 4,949,605 | 17.32B |
| 44 | A | Agilent Technologies, Inc. | 42.80B | 1.25% | 1,102,988 | 7.37B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.73B | -0.51% | 259,668 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 41.16B | 0.92% | 117,353 | 6.13B |
| 47 | WAT | Waters Corporation | 40.51B | 1.59% | 287,750 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.94B | 0.29% | 1,487,030 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.46B | 7.68% | 2,106,625 | 4.80B |
| 50 | ALC | Alcon Inc. | 34.73B | 0.82% | 718,767 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.89B | -0.36% | 880,708 | 4.97B |
| 52 | RMD | ResMed Inc. | 33.73B | 1.05% | 491,268 | 5.65B |
| 53 | CNC | Centene Corporation | 33.33B | 3.45% | 2,306,938 | 180.30B |
| 54 | BIIB | Biogen Inc. | 33.13B | 3.78% | 569,344 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 32.40B | 3.60% | 862,743 | 4.49B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.19B | 1.21% | 1,029,069 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 31.77B | -0.47% | 1,682,327 | 9.53B |
| 58 | MTD | Mettler-Toledo International Inc. | 27.27B | -1.10% | 73,605 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 27.21B | 2.43% | 247,591 | 14.35B |
| 60 | INSM | Insmed Incorporated | 27.11B | 2.17% | 1,029,819 | 1.14B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.77B | 2.66% | 554,379 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 26.12B | -0.53% | 546,507 | 20.18B |
| 63 | BNTX | BioNTech SE | 26.02B | 1.60% | 380,283 | 3.03B |
| 64 | INCY | Incyte Corporation | 25.93B | 2.33% | 937,582 | 5.82B |
| 65 | ROIV | Roivant Sciences Ltd. | 24.28B | -2.64% | 2,660,741 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.16B | 1.37% | 136,069 | 3.33B |
| 67 | STE | STERIS plc | 22.75B | 1.60% | 202,989 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.61B | -2.07% | 983,231 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 21.06B | -4.23% | 685,018 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 20.79B | -2.87% | 495,200 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.88B | 2.43% | 1,333,052 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.60B | 2.62% | 2,761,029 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.15B | 1.02% | 582,614 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.42B | 1.94% | 219,697 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.42B | 0.90% | 97,853 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.00B | 0.44% | 583,941 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.82B | 0.03% | 714,594 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.79B | 1.97% | 252,311 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.91B | -0.40% | 444,479 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.67B | 3.82% | 817,469 | 2.91B |
| 81 | EXEL | Exelixis, Inc. | 14.41B | 2.20% | 1,506,684 | 2.44B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.81B | 2.49% | 221,110 | 4.00B |
| 83 | COO | The Cooper Companies, Inc. | 13.68B | 1.26% | 668,179 | 4.23B |
| 84 | BAX | Baxter International Inc. | 13.42B | 1.90% | 2,069,776 | 11.47B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.96B | 3.24% | 987,012 | 3.41B |
| 86 | PEN | Penumbra, Inc. | 12.75B | 0.38% | 32,954 | 1.50B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.55B | 1.81% | 733,388 | 14.37B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 0.79% | 99,425 | 1.28B |
| 89 | ICLR | ICON Public Limited Company | 12.44B | -0.10% | 449,500 | 8.29B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.40B | 3.76% | 3,796,193 | 5.02B |
| 91 | HALO | Halozyme Therapeutics, Inc. | 12.37B | 1.20% | 762,201 | 1.66B |
| 92 | FMS | Fresenius Medical Care AG | 12.15B | -0.11% | 269,582 | 22.19B |
| 93 | SNN | Smith & Nephew plc | 12.07B | -0.59% | 4,301,762 | 6.30B |
| 94 | EHC | Encompass Health Corporation | 11.98B | -0.47% | 237,648 | 6.21B |
| 95 | CORT | Corcept Therapeutics Incorporated | 11.98B | -2.27% | 504,537 | 830.81M |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.79B | 0.86% | 510,479 | 669.50M |
| 97 | DVA | DaVita Inc. | 11.45B | 1.93% | 239,929 | 14.01B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.36B | 0.56% | 1,669,283 | - |
| 99 | TECH | Bio-Techne Corporation | 11.35B | 0.26% | 1,112,873 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.34B | 2.99% | 303,130 | 4.14B |
| 101 | TEM | Tempus AI, Inc. | 11.06B | -1.57% | 4,488,045 | 1.43B |
| 102 | GMED | Globus Medical, Inc. | 10.97B | 1.49% | 364,082 | 3.14B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.84B | 2.07% | 254,747 | 776.57M |
| 104 | KRYS | Krystal Biotech, Inc. | 10.81B | 0.40% | 119,648 | 440.48M |
| 105 | MOH | Molina Healthcare, Inc. | 10.68B | 1.00% | 147,328 | 42.47B |
| 106 | GKOS | Glaukos Corporation | 10.63B | 2.02% | 225,262 | 612.84M |
| 107 | ABVX | ABIVAX Société Anonyme | 10.48B | -1.01% | 549,128 | 5.67M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.34B | 1.54% | 145,853 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.34B | 0.45% | 512,856 | 3.05B |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.19B | 0.12% | 682,706 | 3.50B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.19B | - | 535,569 | - |
| 112 | IONS | Ionis Pharmaceuticals, Inc. | 10.15B | 1.95% | 917,488 | 874.09M |
| 113 | HSIC | Henry Schein, Inc. | 10.14B | 2.75% | 416,323 | 13.60B |
| 114 | ENSG | The Ensign Group, Inc. | 9.99B | -0.23% | 93,397 | 5.49B |
| 115 | AVTR | Avantor, Inc. | 9.99B | 3.98% | 4,020,413 | 6.56B |
| 116 | UHS | Universal Health Services, Inc. | 9.97B | -0.91% | 338,093 | 18.11B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.94B | 0.37% | 547,141 | 105.00M |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.89B | 0.25% | 149,529 | 7.46M |
| 119 | RGEN | Repligen Corporation | 9.88B | 3.01% | 483,589 | 785.10M |
| 120 | CYTK | Cytokinetics, Incorporated | 9.85B | -0.74% | 626,973 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.42B | -0.59% | 244,107 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.38B | 1.94% | 2,581,630 | 15.32B |
| 123 | QGEN | Qiagen N.V. | 9.16B | 2.12% | 991,965 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 9.12B | 0.76% | 461,526 | - |
| 125 | BRKR | Bruker Corporation | 9.03B | 5.73% | 1,124,718 | 3.50B |
| 126 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | - | - | 42.16M |
| 127 | ATR | AptarGroup, Inc. | 8.34B | 0.18% | 209,681 | 3.93B |
| 128 | IBRX | ImmunityBio, Inc. | 8.32B | -0.25% | 4,128,303 | 165.79M |
| 129 | HQY | HealthEquity, Inc. | 8.15B | 1.55% | 413,038 | 1.36B |
| 130 | TWST | Twist Bioscience Corporation | 8.14B | -1.71% | 1,267,611 | 431.80M |
| 131 | IMVT | Immunovant, Inc. | 8.08B | -1.93% | 651,298 | - |
| 132 | TGTX | TG Therapeutics, Inc. | 8.07B | 1.37% | 1,356,417 | 799.54M |
| 133 | TXG | 10x Genomics, Inc. | 7.96B | 1.83% | 966,201 | 616.91M |
| 134 | ALKS | Alkermes plc | 7.94B | 0.30% | 498,127 | 1.67B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 7.58B | -2.89% | 765,223 | - |
| 136 | HNGE | Hinge Health, Inc. | 7.34B | 1.08% | 589,726 | 720.06M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | 0.01% | 177,391 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 6.97B | -0.44% | 2,977,826 | 989.61M |
| 139 | GRFS | Grifols, S.A. | 6.87B | 1.03% | 115,880 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.84B | 2.03% | 74,450 | 2.60B |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.84B | 3.06% | 4,888,506 | 2.58B |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.79B | -0.20% | 603,002 | - |
| 143 | PACS | PACS Group, Inc. | 6.76B | 1.26% | 312,725 | 5.55B |
| 144 | MMED | MiniMed Group, Inc. | 6.74B | 7.00% | 2,875,275 | 3.22B |
| 145 | CGON | CG Oncology, Inc. | 6.61B | -1.69% | 339,508 | 6.23M |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.06% | 384,409 | 1.56B |
| 147 | BLCO | Bausch + Lomb Corporation | 6.55B | 2.57% | 173,100 | 5.32B |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.42B | 0.49% | 250,109 | 618.07M |
| 149 | BLTE | Belite Bio, Inc | 6.38B | 1.11% | 161,367 | - |
| 150 | AMRX | Amneal Pharmaceuticals, Inc. | 6.29B | 2.21% | 1,391,432 | 3.12B |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.25B | 0.91% | 605,737 | 591.33M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.20B | 0.19% | 230,948 | 840.85M |
| 153 | LQDA | Liquidia Corporation | 6.10B | 1.93% | 497,438 | 450.91M |
| 154 | ORKA | Oruka Therapeutics, Inc. | 6.05B | -0.83% | 343,176 | - |
| 155 | TFX | Teleflex Incorporated | 6.02B | 1.11% | 491,957 | 2.25B |
| 156 | RDNT | RadNet, Inc. | 6.01B | 1.17% | 336,487 | 2.27B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.96B | -1.07% | 528,609 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.95B | 1.02% | 473,555 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.94B | -0.42% | 206,046 | 1.90M |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | 0.72% | 322,797 | 7.50M |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 5.69B | 0.40% | 76,624 | 290.54M |
| 162 | STVN | Stevanato Group S.p.A. | 5.59B | -1.11% | 131,805 | 1.40B |
| 163 | ERAS | Erasca, Inc. | 5.53B | -5.64% | 2,411,834 | - |
| 164 | CRSP | CRISPR Therapeutics AG | 5.46B | -0.56% | 486,636 | 13.39M |
| 165 | SHC | Sotera Health Company | 5.41B | 1.50% | 632,610 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.39B | -0.37% | 214,535 | 1.58B |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.15B | -0.42% | 734,380 | - |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.05B | 1.38% | 537,995 | 1.14B |
| 169 | LFST | LifeStance Health Group, Inc. | 4.96B | 2.94% | 1,898,420 | 1.58B |
| 170 | WAY | Waystar Holding Corp. | 4.94B | -0.08% | 642,141 | 1.21B |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.86B | -0.38% | 194,631 | 148.00K |
| 172 | HAE | Haemonetics Corporation | 4.72B | 1.86% | 258,276 | 1.35B |
| 173 | DOCS | Doximity, Inc. | 4.71B | 0.19% | 986,160 | 655.57M |
| 174 | DYN | Dyne Therapeutics, Inc. | 4.70B | 0.20% | 1,000,925 | - |
| 175 | CELC | Celcuity Inc. | 4.63B | 2.76% | 447,792 | - |
| 176 | LIVN | LivaNova PLC | 4.57B | 3.37% | 333,558 | 1.47B |
| 177 | BLLN | BillionToOne, Inc. | 4.55B | 4.41% | 236,610 | 397.41M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.48B | -2.46% | 361,341 | - |
| 179 | NVST | Envista Holdings Corporation | 4.43B | 3.42% | 700,620 | 2.86B |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.37B | 1.15% | 236,083 | 2.29B |
| 181 | HTFL | HeartFlow, Inc. | 4.37B | -0.44% | 867,937 | 212.07M |
| 182 | ELVN | Enliven Therapeutics, Inc. | 4.31B | 1.78% | 345,484 | - |
| 183 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.31B | 1.51% | 912,246 | -665.00K |
| 184 | ICUI | ICU Medical, Inc. | 4.27B | 0.04% | 165,374 | 2.16B |
| 185 | ITGR | Integer Holdings Corporation | 4.26B | -0.03% | 385,282 | 1.84B |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.14B | 1.42% | 942,557 | 1.33B |
| 187 | LEGN | Legend Biotech Corporation | 4.13B | 0.95% | 647,544 | 1.27B |
| 188 | MANE | Veradermics, Incorporated | 4.04B | -0.74% | 208,748 | - |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.04B | 0.09% | 157,881 | 825.34M |
| 190 | RLAY | Relay Therapeutics, Inc. | 4.01B | -0.92% | 821,520 | 10.35M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.93B | 1.11% | 740,499 | 308.08M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.87B | -1.57% | 990,258 | - |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.85B | 2.78% | 7,929,511 | 324.97M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.23% | 345,209 | 234.13M |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.82B | 5.16% | 210,025 | 890.79M |
| 196 | TNGX | Tango Therapeutics, Inc. | 3.80B | 0.72% | 1,097,292 | 53.81M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.77B | -0.30% | 602,085 | 117.00M |
| 198 | PLSE | Pulse Biosciences, Inc. | 3.76B | 1.15% | 606,251 | 1.19M |
| 199 | OGN | Organon & Co. | 3.62B | 0.07% | 2,124,221 | 6.13B |
| 200 | DNLI | Denali Therapeutics Inc. | 3.62B | -2.77% | 937,281 | 3.60M |
| 201 | GRAL | GRAIL, Inc. | 3.61B | 1.35% | 229,460 | 165.26M |
| 202 | OPCH | Option Care Health, Inc. | 3.59B | 1.40% | 507,473 | 5.69B |
| 203 | VCYT | Veracyte, Inc. | 3.59B | 2.81% | 651,379 | 561.90M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.58B | 10.16% | 988,807 | 606.33M |
| 205 | ABCL | AbCellera Biologics Inc. | 3.55B | -2.93% | 2,526,719 | 66.17M |
| 206 | NHC | National HealthCare Corporation | 3.43B | -0.04% | 56,879 | 1.56B |
| 207 | GPCR | Structure Therapeutics Inc. | 3.30B | -1.72% | 430,484 | - |
| 208 | QURE | uniQure N.V. | 3.14B | -5.29% | 1,648,479 | 18.67M |
| 209 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -0.03% | 156,865 | 158.00K |
| 210 | IMNM | Immunome, Inc. | 3.07B | 0.02% | 380,119 | 4.02M |
| 211 | IRON | Disc Medicine, Inc. | 3.06B | 1.46% | 238,234 | - |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | 2.77% | 440,874 | 7.12M |
| 213 | WRBY | Warby Parker Inc. | 3.02B | 1.16% | 832,891 | 911.61M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | 0.21% | 924,537 | 463.98M |
| 215 | RGC | Regencell Bioscience Holdings Limited | 2.96B | 8.55% | 197,084 | - |
| 216 | ZLAB | Zai Lab Limited | 2.94B | 3.44% | 680,138 | 449.61M |
| 217 | TMDX | TransMedics Group, Inc. | 2.90B | 1.81% | 215,545 | 668.47M |
| 218 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -1.78% | 994,478 | 2.60B |
| 219 | MBX | MBX Biosciences, Inc. | 2.88B | -1.85% | 174,935 | - |
| 220 | BKD | Brookdale Senior Living Inc. | 2.87B | 1.05% | 1,349,859 | 2.93B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.86B | -1.27% | 759,218 | 156.04M |
| 222 | ALHC | Alignment Healthcare, Inc. | 2.86B | 1.40% | 1,178,494 | 4.58B |
| 223 | SLS | SELLAS Life Sciences Group, Inc. | 2.78B | 4.31% | 3,780,482 | - |
| 224 | ATAI | AtaiBeckley Inc. | 2.72B | -0.07% | 4,832,540 | 4.47M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.66B | -1.75% | 564,520 | 36.77M |
| 226 | PRVA | Privia Health Group, Inc. | 2.65B | 0.48% | 608,596 | 2.36B |
| 227 | AXGN | Axogen, Inc. | 2.64B | -1.64% | 267,617 | 251.17M |
| 228 | NEOG | Neogen Corporation | 2.61B | 2.96% | 810,438 | 870.40M |
| 229 | ATRC | AtriCure, Inc. | 2.60B | 4.66% | 650,165 | 569.62M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.57B | -2.16% | 421,448 | 3.37B |
| 231 | CDNA | CareDx, Inc. | 2.57B | 1.35% | 456,162 | 458.09M |
| 232 | WGS | GeneDx Holdings Corp. | 2.56B | 1.40% | 266,500 | 454.43M |
| 233 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.56B | 1.11% | 1,469,282 | 940.61M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 0.97% | 773,122 | 717.00M |
| 235 | VRDN | Viridian Therapeutics, Inc. | 2.56B | -1.87% | 662,944 | 71.13M |
| 236 | SUPN | Supernus Pharmaceuticals, Inc. | 2.55B | 0.46% | 200,899 | 830.44M |
| 237 | PBH | Prestige Consumer Healthcare Inc. | 2.55B | 2.20% | 155,696 | 1.10B |
| 238 | BHC | Bausch Health Companies Inc. | 2.54B | 4.79% | 1,602,362 | 10.85B |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.52B | 11.50% | 1,136,499 | - |
| 240 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | 1.36% | 184,402 | 1.46B |
| 241 | VERA | Vera Therapeutics, Inc. | 2.49B | 1.11% | 520,331 | - |
| 242 | HRMY | Harmony Biosciences Holdings, Inc. | 2.48B | 3.30% | 534,994 | 959.90M |
| 243 | PGEN | Precigen, Inc. | 2.48B | 0.95% | 1,394,237 | 85.72M |
| 244 | NKTR | Nektar Therapeutics | 2.45B | - | 193,384 | 54.59M |
| 245 | PHVS | Pharvaris N.V. | 2.45B | -0.14% | 183,878 | - |
| 246 | SRPT | Sarepta Therapeutics, Inc. | 2.41B | 6.89% | 2,573,134 | 1.97B |
| 247 | BHVN | Biohaven Ltd. | 2.39B | 0.38% | 1,721,735 | - |
| 248 | TRVI | Trevi Therapeutics, Inc. | 2.39B | 1.09% | 582,420 | - |
| 249 | NUVB | Nuvation Bio Inc. | 2.38B | 2.26% | 2,711,466 | 169.90M |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.36B | 1.80% | 1,156,040 | 52.06M |
| 251 | TRLV | Trulieve Cannabis Corp. | 2.33B | 2.98% | 1,214,050 | 1.14B |
| 252 | RAPP | Rapport Therapeutics, Inc. | 2.33B | -0.15% | 136,100 | 20.00M |
| 253 | KOD | Kodiak Sciences Inc. | 2.32B | -0.32% | 245,022 | - |
| 254 | XRAY | DENTSPLY SIRONA Inc. | 2.29B | 6.97% | 2,781,063 | 3.64B |
| 255 | CLOV | Clover Health Investments, Corp. | 2.29B | 0.35% | 1,839,636 | 2.48B |
| 256 | UFPT | UFP Technologies, Inc. | 2.27B | -0.31% | 87,532 | 631.64M |
| 257 | NEO | NeoGenomics, Inc. | 2.25B | 0.40% | 831,275 | 766.30M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 2.21B | 6.41% | 213,429 | 245.82M |
| 259 | MESO | Mesoblast Limited | 2.20B | 4.00% | 95,628 | 120.25M |
| 260 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 0.71% | 65,438 | - |
| 261 | ZYME | Zymeworks Inc. | 2.17B | 2.86% | 287,372 | 37.13M |
| 262 | ADUS | Addus HomeCare Corporation | 2.16B | 3.20% | 138,373 | 1.48B |
| 263 | MD | Pediatrix Medical Group, Inc. | 2.16B | 2.72% | 398,071 | 1.95B |
| 264 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | 0.93% | 343,473 | 311.51M |
| 265 | URGN | UroGen Pharma Ltd. | 2.15B | 1.22% | 230,282 | 188.73M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 2.14B | 2.69% | 530,444 | 1.00M |
| 267 | ADMA | ADMA Biologics, Inc. | 2.13B | 1.93% | 908,228 | 512.28M |
| 268 | COAG | Hemab Therapeutics Holdings, Inc. | 2.11B | 2.75% | 160,361 | - |
| 269 | ALMR | Alamar Biosciences, Inc. | 2.10B | 3.30% | 114,884 | 100.42M |
| 270 | VCEL | Vericel Corporation | 2.09B | 0.59% | 180,975 | 306.30M |
| 271 | KARD | Kardigan, Inc. | 2.08B | 13.57% | 171,592 | - |
| 272 | HCM | HUTCHMED (China) Limited | 2.08B | 1.28% | 44,060 | 549.12M |
| 273 | NVCR | NovoCure Limited | 2.08B | 2.70% | 534,588 | 699.19M |
| 274 | PRGO | Perrigo Company plc | 2.06B | 2.81% | 791,000 | 4.14B |
| 275 | GENB | Generate Biomedicines, Inc. | 2.06B | 1.46% | 550,688 | 26.48M |
| 276 | KLRA | Kailera Therapeutics, Inc. | 2.05B | -3.47% | 403,787 | - |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -0.26% | 246,176 | 98.34M |
| 278 | BFLY | Butterfly Network, Inc. | 2.03B | -6.60% | 3,030,263 | 112.14M |
| 279 | PGNY | Progyny, Inc. | 2.03B | 3.00% | 494,377 | 1.31B |
| 280 | ASTH | Astrana Health, Inc. | 1.99B | 0.75% | 92,646 | 3.84B |
| 281 | NBTX | Nanobiotix S.A. | 1.97B | 5.55% | 166,537 | 38.27M |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.95B | -2.23% | 279,951 | 27.59M |
| 283 | XNCR | Xencor, Inc. | 1.94B | -6.34% | 437,633 | 104.97M |
| 284 | VIR | Vir Biotechnology, Inc. | 1.93B | -1.81% | 1,671,362 | 303.23M |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 1.85% | 1,739,746 | 208.78M |
| 286 | ALVO | Alvotech | 1.90B | 1.81% | 394,619 | 494.61M |
| 287 | GHRS | GH Research PLC | 1.90B | 1.10% | 50,065 | - |
| 288 | IMCR | Immunocore Holdings plc | 1.89B | -0.19% | 80,477 | 430.78M |
| 289 | LMAT | LeMaitre Vascular, Inc. | 1.87B | 0.59% | 112,871 | 262.43M |
| 290 | SGRY | Surgery Partners, Inc. | 1.86B | -1.64% | 506,476 | 3.37B |
| 291 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 1.94% | 92,136 | 1.13B |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | 2.79% | 621,815 | 252.25M |
| 293 | INSP | Inspire Medical Systems, Inc. | 1.84B | 3.32% | 178,087 | 898.74M |
| 294 | INBX | Inhibrx Biosciences, Inc. | 1.83B | -0.22% | 89,727 | 1.30M |
| 295 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | -1.84% | 893,487 | 5.49M |
| 296 | CMPS | COMPASS Pathways plc | 1.81B | -1.02% | 1,267,506 | - |
| 297 | PSNL | Personalis, Inc. | 1.81B | -0.70% | 1,504,229 | 69.67M |
| 298 | SNDA | Sonida Senior Living, Inc. | 1.80B | 0.34% | 203,717 | 481.07M |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | 0.15% | 8,407,456 | 54.86M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.77B | 1.87% | 337,240 | 106.69M |
| 301 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -0.99% | 2,079,452 | 59.51M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.75B | 1.57% | 274,291 | 105.60M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.75B | 3.92% | 376,807 | 2.68B |
| 304 | SEPN | Septerna, Inc. | 1.74B | -1.01% | 128,035 | 98.88M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.74B | 0.21% | 199,398 | - |
| 306 | BRVE | Braveheart Bio, Inc. | 1.74B | 3.12% | 234,761 | - |
| 307 | FRNM | Freenome, Inc. | 1.70B | 3.54% | 699,226 | 35.41M |
| 308 | NVAX | Novavax, Inc. | 1.69B | 0.99% | 3,307,304 | 413.80M |
| 309 | TRAX | First Tracks Biotherapeutics, Inc. | 1.66B | 12.97% | 848,004 | - |
| 310 | PAHC | Phibro Animal Health Corporation | 1.64B | 5.38% | 132,437 | 1.52B |
| 311 | ANAB | AnaptysBio, Inc. | 1.64B | 0.25% | 234,545 | 232.39M |
| 312 | SLBT | SL Science Holding Limited | 1.62B | 1.97% | 32,440 | 3.27M |
| 313 | LBRX | LB Pharmaceuticals Inc | 1.59B | 4.67% | 251,654 | - |
| 314 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | 1.72% | 96,089 | 978.38M |
| 315 | OMCL | Omnicell, Inc. | 1.57B | -0.52% | 160,759 | 1.25B |
| 316 | AVLN | Avalyn Pharma Inc. | 1.56B | -0.31% | 77,513 | - |
| 317 | SDGR | Schrödinger, Inc. | 1.55B | -0.34% | 780,035 | 259.04M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | 0.95% | 657,793 | 335.41M |
| 319 | APMD | Apnimed, Inc. | 1.55B | 4.06% | 154,727 | 120.15M |
| 320 | ARDT | Ardent Health, Inc. | 1.55B | 0.27% | 188,914 | 6.41B |
| 321 | BCAX | Bicara Therapeutics Inc. | 1.54B | -0.45% | 230,538 | - |
| 322 | INVA | Innoviva, Inc. | 1.54B | 1.14% | 203,172 | 440.00M |
| 323 | AAPG | Ascentage Pharma Group International | 1.53B | 3.51% | 1,513 | 94.61M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.52B | 1.79% | 233,072 | 1.86B |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | 2.79% | 117,679 | 95.13M |
| 326 | REPL | Replimune Group, Inc. | 1.50B | 1.79% | 910,627 | - |
| 327 | CNMD | CONMED Corporation | 1.50B | 1.87% | 94,147 | 1.37B |
| 328 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.95% | 166,139 | - |
| 329 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 0.40% | 254,078 | - |
| 330 | ABSI | Absci Corporation | 1.48B | -2.38% | 1,880,007 | 1.56M |
| 331 | AGL | agilon health, inc. | 1.47B | 0.19% | 54,332 | 5.92B |
| 332 | HROW | Harrow, Inc. | 1.46B | 5.36% | 195,170 | 275.59M |
| 333 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.94% | 181,839 | 20.00M |
| 334 | INNV | InnovAge Holding Corp. | 1.46B | -0.74% | 73,924 | 949.17M |
| 335 | AKTS | Aktis Oncology, Inc. | 1.46B | 0.71% | 157,625 | 10.06M |
| 336 | VOR | Vor Biopharma Inc. | 1.45B | 7.99% | 457,764 | - |
| 337 | TNDM | Tandem Diabetes Care, Inc. | 1.44B | -2.58% | 433,406 | 1.04B |
| 338 | ANRO | Alto Neuroscience, Inc. | 1.44B | 4.42% | 174,035 | - |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.42B | 0.05% | 665,686 | 815.05M |
| 340 | OMDA | Omada Health, Inc. | 1.42B | 1.71% | 512,151 | 309.76M |
| 341 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | 1.28% | 362,255 | - |
| 342 | AZTA | Azenta, Inc. | 1.41B | 1.82% | 337,685 | 613.81M |
| 343 | SVRA | Savara Inc. | 1.38B | 1.59% | 572,355 | - |
| 344 | LTGO | Latigo Biotherapeutics, Inc. | 1.37B | -2.74% | 82,209 | - |
| 345 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | 1.09% | 296,454 | - |
| 346 | OMER | Omeros Corporation | 1.35B | -0.53% | 639,385 | 38.42M |
| 347 | ALMS | Alumis Inc. | 1.34B | 8.98% | 7,310,365 | 7.40M |
| 348 | MGTX | MeiraGTx Holdings plc | 1.33B | -2.40% | 302,144 | 397.50M |
| 349 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 5.04% | 77,800 | - |
| 350 | PNTG | The Pennant Group, Inc. | 1.32B | 0.37% | 102,026 | 1.10B |
| 351 | NUTX | Nutex Health Inc. | 1.32B | 2.98% | 80,250 | 846.72M |
| 352 | JBIO | Jade Biosciences, Inc. | 1.32B | -1.19% | 179,079 | - |
| 353 | DRTS | Alpha Tau Medical Ltd. | 1.31B | 1.65% | 202,495 | - |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.31B | 1.32% | 212,116 | 1.65B |
| 355 | AMN | AMN Healthcare Services, Inc. | 1.31B | 0.54% | 199,217 | 3.43B |
| 356 | AORT | Artivion, Inc. | 1.30B | -1.37% | 148,312 | 471.47M |
| 357 | MNKD | MannKind Corporation | 1.30B | 1.63% | 1,139,947 | 393.63M |
| 358 | IMTX | Immatics N.V. | 1.29B | -0.21% | 314,190 | 47.65M |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.27B | -1.19% | 390,712 | - |
| 360 | OPK | OPKO Health, Inc. | 1.27B | 11.51% | 4,362,127 | 587.90M |
| 361 | CERT | Certara, Inc. | 1.26B | 1.85% | 585,141 | 421.75M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.26B | 4.88% | 608,756 | 337.34M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.25B | 6.22% | 77,094 | 99.00K |
| 364 | CRON | Cronos Group Inc. | 1.24B | -3.11% | 519,175 | 179.09M |
| 365 | BVS | Bioventus Inc. | 1.21B | 5.56% | 290,072 | 581.85M |
| 366 | GDRX | GoodRx Holdings, Inc. | 1.21B | 2.75% | 664,320 | 785.23M |
| 367 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -0.91% | 725,272 | 28.73M |
| 368 | ENOV | Enovis Corporation | 1.19B | 0.71% | 1,335,746 | 2.30B |
| 369 | JANX | Janux Therapeutics, Inc. | 1.19B | 3.10% | 1,060,476 | 24.00M |
| 370 | TDOC | Teladoc Health, Inc. | 1.19B | 4.63% | 1,986,363 | 2.49B |
| 371 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -1.26% | 266,351 | - |
| 372 | STAA | STAAR Surgical Company | 1.17B | -0.55% | 196,063 | 339.59M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 0.70% | 53,000 | 804.27M |
| 374 | SANA | Sana Biotechnology, Inc. | 1.16B | 1.44% | 1,331,693 | - |
| 375 | KURA | Kura Oncology, Inc. | 1.15B | 0.08% | 876,087 | 77.23M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.64% | 95,028 | 1.04B |
| 377 | IVA | Inventiva S.A. | 1.11B | 1.68% | 553,376 | 7.94M |
| 378 | IRMD | IRADIMED CORPORATION | 1.11B | 0.11% | 40,674 | 86.34M |
| 379 | SLDB | Solid Biosciences Inc. | 1.07B | 0.81% | 462,274 | - |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.06B | 0.23% | 251,500 | 746.16M |
| 381 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -0.41% | 37,394 | - |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.04B | 2.32% | 451,259 | 59.00K |
| 383 | GERN | Geron Corporation | 1.02B | 7.77% | 13,118,501 | 204.56M |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.69% | 1,471,981 | 181.72M |
| 385 | FTH | Faeth Therapeutics, Inc. | 1.01B | 13.16% | 417,501 | - |
| 386 | GMRS | GMR Solutions Inc. | 1.01B | -0.04% | 280,205 | 5.88B |
| 387 | CSTL | Castle Biosciences, Inc. | 1.01B | -1.59% | 95,232 | 357.28M |
| 388 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | 2.92% | 167,843 | 730.02M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | 2.97% | 875,276 | 41.47M |
| 390 | IMMX | Immix Biopharma, Inc. | 989.39M | -1.28% | 1,085,223 | - |
| 391 | CADL | Candel Therapeutics, Inc. | 987.09M | 0.39% | 445,805 | - |
| 392 | ATTO | Attovia Therapeutics, Inc. | 983.64M | 2.88% | 34,584 | 1.35M |
| 393 | DSGN | Design Therapeutics, Inc. | 974.40M | 2.84% | 510,232 | - |
| 394 | QDEL | QuidelOrtho Corporation | 958.00M | 1.60% | 378,187 | 2.67B |
| 395 | SGP | SpyGlass Pharma, Inc. | 942.06M | 4.86% | 67,730 | - |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 941.47M | 1.89% | 401,797 | - |
| 397 | WVE | Wave Life Sciences, Inc. | 939.92M | -4.02% | 2,909,829 | 65.37M |
| 398 | CBLL | CeriBell, Inc. | 939.88M | -0.37% | 210,249 | 101.96M |
| 399 | ARDX | Ardelyx, Inc. | 933.21M | -0.40% | 1,718,505 | 450.89M |
| 400 | ANNX | Annexon, Inc. | 925.15M | -0.20% | 813,932 | - |
| 401 | RIGL | Rigel Pharmaceuticals, Inc. | 908.59M | 2.40% | 77,520 | 276.79M |
| 402 | ANL | Adlai Nortye Group Ltd. | 894.49M | 1.91% | 45,481 | 18.06M |
| 403 | SLN | Silence Therapeutics plc | 888.69M | 0.14% | 377,360 | 615.00K |
| 404 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.12% | 289,741 | 104.31M |
| 405 | ACRS | Aclaris Therapeutics, Inc. | 883.93M | -0.25% | 834,086 | 8.22M |
| 406 | HSTM | HealthStream, Inc. | 875.15M | 0.88% | 71,851 | 321.12M |
| 407 | CLYM | Climb Bio, Inc. | 866.14M | 1.75% | 1,525,448 | - |
| 408 | ACHV | Achieve Life Sciences, Inc. | 865.41M | 1.94% | 583,666 | - |
| 409 | INMD | InMode Ltd. | 861.64M | -0.27% | 213,335 | 374.63M |
| 410 | BBNX | Beta Bionics, Inc. | 858.40M | 0.05% | 248,146 | 119.01M |
| 411 | HELP | Cybin Inc. | 854.80M | 0.86% | 900,696 | - |
| 412 | SIBN | SI-BONE, Inc. | 852.45M | 0.53% | 297,896 | 213.60M |
| 413 | AVR | Anteris Technologies Global Corp. | 839.12M | 1.89% | 205,150 | 2.24M |
| 414 | DBVT | DBV Technologies S.A. | 813.62M | 2.24% | 127,516 | 5.04M |
| 415 | AHCO | AdaptHealth Corp. | 811.13M | 10.34% | 2,053,580 | 3.36B |
| 416 | CTMX | CytomX Therapeutics, Inc. | 808.41M | 1.09% | 3,861,792 | 18.30M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 803.53M | 1.36% | 277,552 | 92.01M |
| 418 | GLAS | Glass House Brands Inc. | 802.47M | 0.29% | 312,597 | 176.98M |
| 419 | PHAR | Pharming Group N.V. | 798.86M | 0.81% | 4,345 | 366.48M |
| 420 | COLL | Collegium Pharmaceutical, Inc. | 790.12M | 1.12% | 423,361 | 808.21M |
| 421 | CBIO | Crescent Biopharma, Inc. | 790.11M | 2.96% | 123,353 | 11.88M |
| 422 | MNPR | Monopar Therapeutics Inc. | 779.62M | -1.21% | 137,281 | - |
| 423 | VREX | Varex Imaging Corporation | 778.89M | 0.05% | 405,717 | 865.00M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 770.55M | 2.56% | 78,308 | - |
| 425 | AURA | Aura Biosciences, Inc. | 767.93M | -0.34% | 250,314 | - |
| 426 | NGNE | Neurogene Inc. | 761.43M | 0.48% | 112,859 | 925.00K |
| 427 | OABI | OmniAb, Inc. | 753.85M | 16.78% | 4,137,474 | 38.46M |
| 428 | AHG | Akso Health Group | 745.33M | -3.33% | 11,551 | 13.83M |
| 429 | ASMB | Assembly Biosciences, Inc. | 741.43M | 3.51% | 141,618 | 74.85M |
| 430 | OCS | Oculis Holding AG | 740.78M | -1.48% | 126,835 | 1.45M |
| 431 | PHR | Phreesia, Inc. | 736.80M | 0.68% | 236,754 | 495.59M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 733.67M | 3.98% | 1,278,431 | 389.32M |
| 433 | MPLT | MapLight Therapeutics, Inc. | 728.04M | -1.58% | 500,567 | - |
| 434 | PHAT | Phathom Pharmaceuticals, Inc. | 724.40M | -2.88% | 460,599 | 239.66M |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 722.70M | 0.91% | 764,000 | 136.07M |
| 436 | VSTM | Verastem, Inc. | 719.53M | 4.40% | 4,135,942 | 87.53M |
| 437 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 702.33M | -0.68% | 121,572 | - |
| 438 | DRUG | Bright Minds Biosciences Inc. | 693.29M | 1.06% | 38,875 | - |
| 439 | STTK | Shattuck Labs, Inc. | 690.50M | 0.15% | 330,816 | 1.00M |
| 440 | SOPH | SOPHiA GENETICS SA | 681.02M | -5.04% | 580,057 | 86.17M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 680.60M | -0.79% | 33,996 | 109.82M |
| 442 | SSII | SS Innovations International, Inc. | 678.30M | 1.35% | 48,380 | 52.40M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 670.23M | 1.91% | 1,217,644 | 54.09M |
| 444 | AGMB | AgomAb Therapeutics NV | 668.79M | 0.30% | 36,838 | - |
| 445 | CTEV | Claritev Corporation | 667.98M | 0.17% | 40,157 | 994.67M |
| 446 | MDXG | MiMedx Group, Inc. | 666.85M | 1.22% | 390,111 | 355.17M |
| 447 | ALLO | Allogene Therapeutics, Inc. | 663.34M | -3.27% | 3,300,992 | 4.64M |
| 448 | SGMT | Sagimet Biosciences Inc. | 663.23M | 1.62% | 351,690 | - |
| 449 | CRMD | CorMedix Inc. | 656.29M | 0.48% | 567,920 | 462.25M |
| 450 | EVO | Evotec SE | 649.10M | 5.56% | 26,384 | 819.47M |
| 451 | ANGO | AngioDynamics, Inc. | 647.68M | -1.20% | 110,174 | 320.17M |
| 452 | PRME | Prime Medicine, Inc. | 642.23M | 1.12% | 1,469,808 | 4.07M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 641.25M | 2.99% | 181,866 | - |
| 454 | ALT | Altimmune, Inc. | 629.26M | 4.69% | 5,344,340 | 31.00K |
| 455 | TLRY | Tilray Brands, Inc. | 622.47M | 2.00% | 2,165,305 | 915.45M |
| 456 | RGNX | REGENXBIO Inc. | 619.86M | 0.75% | 273,946 | 174.48M |
| 457 | VALN | Valneva SE | 616.91M | 7.20% | 90,138 | 163.30M |
| 458 | STLN | Starling Oncology, Inc. | 616.59M | 1.85% | 491,589 | 587.24M |
| 459 | ARVN | Arvinas, Inc. | 616.59M | 1.62% | 206,812 | 316.70M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 602.86M | 2.30% | 210,961 | - |
| 461 | CTKB | Cytek Biosciences, Inc. | 602.47M | 0.32% | 242,217 | 206.71M |
| 462 | SCTX | Scribe Therapeutics Inc. | 601.68M | 9.98% | 231,682 | 36.28M |
| 463 | KIDS | OrthoPediatrics Corp. | 600.26M | -0.04% | 124,922 | 252.72M |
| 464 | EOLS | Evolus, Inc. | 594.45M | -0.88% | 362,710 | 316.49M |
| 465 | CABA | Cabaletta Bio, Inc. | 593.41M | 6.06% | 5,619,953 | - |
| 466 | AUTL | Autolus Therapeutics plc | 592.21M | -3.68% | 1,633,910 | 117.39M |
| 467 | TECX | Tectonic Therapeutic, Inc. | 587.17M | -3.80% | 87,486 | - |
| 468 | WEAV | Weave Communications, Inc. | 585.19M | 0.21% | 1,674,851 | 257.79M |
| 469 | BLSM | BlossomHill Therapeutics, Inc. | 581.92M | - | 69,560 | - |
| 470 | PROK | ProKidney Corp. | 580.46M | 3.78% | 353,241 | 818.00K |
| 471 | SPRY | ARS Pharmaceuticals, Inc. | 576.30M | 0.43% | 562,557 | 116.93M |
| 472 | BWAY | BrainsWay Ltd. | 574.10M | -0.28% | 57,789 | 60.70M |
| 473 | DCTH | Delcath Systems, Inc. | 571.06M | 0.35% | 247,669 | 95.42M |
| 474 | CAPR | Capricor Therapeutics, Inc. | 569.76M | -2.10% | 3,542,686 | 11.13M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 564.41M | -0.18% | 180,591 | 22.42M |
| 476 | FLGT | Fulgent Genetics, Inc. | 548.38M | 1.74% | 178,914 | 323.93M |
| 477 | ARTV | Artiva Biotherapeutics, Inc. | 546.10M | -0.98% | 168,525 | 251.00K |
| 478 | ZURA | Zura Bio Limited | 540.48M | -0.18% | 455,989 | - |
| 479 | OVID | Ovid Therapeutics Inc. | 530.23M | -1.63% | 590,668 | 1.58M |
| 480 | NPCE | NeuroPace, Inc. | 528.94M | 4.55% | 89,436 | 106.99M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 527.52M | 2.16% | 393,113 | - |
| 482 | SENS | Senseonics Holdings, Inc. | 521.34M | 5.12% | 474,722 | 48.55M |
| 483 | CERS | Cerus Corporation | 520.94M | -0.96% | 1,099,348 | 221.55M |
| 484 | TCMD | Tactile Systems Technology, Inc. | 513.07M | 1.80% | 149,142 | 350.31M |
| 485 | ENTX | Entera Bio Ltd. | 504.71M | 0.52% | 90,355 | 42.00K |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | PBYI | Puma Biotechnology, Inc. | 496.07M | 2.78% | 151,254 | 231.24M |
| 488 | PRTA | Prothena Corporation plc | 493.35M | - | 143,587 | 54.53M |
| 489 | EVH | Evolent Health, Inc. | 485.02M | 0.23% | 615,003 | 2.10B |
| 490 | ARCT | Arcturus Therapeutics Holdings Inc. | 479.50M | 3.98% | 1,275,203 | 29.37M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 478.41M | 0.56% | 685,864 | - |
| 492 | SRTA | Strata Critical Medical, Inc. | 478.16M | 0.65% | 658,926 | 255.98M |
| 493 | KMDA | Kamada Ltd. | 474.61M | 0.24% | 155,859 | 191.85M |
| 494 | SGHT | Sight Sciences, Inc. | 472.10M | 4.64% | 176,477 | 83.38M |
| 495 | RZLT | Rezolute, Inc. | 469.06M | -0.22% | 409,107 | - |
| 496 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | 0.43% | 649,772 | 132.42M |
| 497 | EDIT | Editas Medicine, Inc. | 468.42M | -0.65% | 976,666 | 47.01M |
| 498 | CCCC | C4 Therapeutics, Inc. | 465.04M | -2.33% | 1,055,443 | 35.04M |
| 499 | VOGX | Vogenx, Inc. | 460.25M | -0.18% | 209,169 | - |
| 500 | IKT | Inhibikase Therapeutics, Inc. | 458.83M | 5.88% | 195,440 | 1.00 |